期刊文献+

阿托伐他汀钙治疗急性脑梗死合并高脂血症及颈动脉粥样硬化斑块患者的疗效分析 被引量:27

Clinical Observation of Atorvastatin Calcium for Acute Cerebral Infarction with Hyperlipidemia and Carotid Artery Atherosclerosis
暂未订购
导出
摘要 目的探讨阿托伐他汀治疗急性脑梗死合并高脂血症、颈动脉粥样硬化斑块患者的临床疗效。方法选择急性脑梗死合并高脂血症、颈动脉粥样硬化斑块患者62例,在神经科常规治疗基础上给予阿托伐他汀联合治疗,分别于入院时,治疗第8、12、24周动态监测患者的血脂水平,并进行颈动脉超声检查评估颈动脉粥样硬化斑块内膜-中层厚度。结果治疗前、后比较,患者各项血脂指标、颈动脉斑块内膜-中层厚度均有显著改善,差异有统计学意义(P<0.05);且神经功能缺损较治疗前显著改善,有效率为59.7%。结论阿托伐他汀除有良好的降血脂作用外,还有稳定甚至减轻动脉粥样硬化的作用。 Objective To evaluate the clinical effect of atorvastatin calcium for acute cerebral infarction with hyperlipidemia and carotid artery atherosclerosis.Methods Sixty-two patients with acute cerebral infarction complicated with hyperlipemia and atherosclerotic plaque were choosen,and therapeutic alliance of atorvastatin was given on the basis of conventional therapy,the level of blood fat was dynamically monitored in admission time,in 8,12,24 weeks after treatment,carotid ultrasound was performed to evaluate the thickness of inner membrance-intercellular layer of carotid atherosclerotic plaque.Results The blood lipids and the thickness of inner membrance-intercellular layer of carotid atherosclerotic plaque were significantly improved than those for pretherapy(P〈0.05);neurologic impairment were obviously improved than that in prior treatment,the effective rate was 59.7%.Conclusion Atorvastatin has stabilized even ruduced atherosclerotic besides its anti-lipidic role.
出处 《医学综述》 2010年第11期1743-1745,共3页 Medical Recapitulate
关键词 阿托伐他汀 脑梗死 高脂血症 动脉粥样硬化 Atorvastatin Cerebral infarction Hyperlipidemia Atherosclerosis
  • 相关文献

参考文献13

二级参考文献15

  • 1王振杰,田秀芝,李贤,陈祚,赵连成,周北凡,武阳丰,中国高胆固醇血症控制状况调查协作组.药物治疗的高胆固醇血症患者膳食治疗状况与血脂控制达标率——高胆固醇血症临床控制状况多中心协作研究[J].中华心血管病杂志,2005,33(4):372-375. 被引量:17
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33099
  • 3李红霞,满永,国汉邦,唐蔚青,夏永静,董军,王抒,李健斋.北京市部分人群血压、血糖、血脂异常的知晓率、治疗率和达标率的调查[J].北京医学,2007,29(1):57-57. 被引量:17
  • 4Heart Protection Study Collaborative Group: Medical Research Council/ British Heart Foundation Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risle individuals: a randomised placebocontrolled trial[ J] .Lancet,2002,306:7.
  • 5Corvol JC, Bouzamaondo A, Sirol M, et al. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials [ J]. Arch Intern Med,2003,163:669.
  • 6Cook NR, Cohen J, Hekbert PR, et al. Implications of small reductions in diastolic blood pressure for primary prevention[J]. Arch Intern Med, 1995,155:701.
  • 7He J,Gu D,Reynolds K,et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[ J]. Circulation ,2004,110(4 ) :405 - 411.
  • 8[1]Sacco RL,Ben jamin EJ,Brogerick JP,et al.American Heart Association Prevention Conference IV.Prevention and rehabilitation of stork risk factors[J].Stroke,1997,28:1507-1517.
  • 9[2]Hoougaku H,M,H anda N,Maedu H,itoh T,Tsukamoto Y,Kamada T Asymptomatic carotid lesions and silent cerebral.Infarction[J].Stroke,1994,25:566-570.
  • 10[3]Hegland O,Dickstein K,Larsen JP.Effect of simvastatin in preventing progression of carotid artery stenosis[J].Am J Cardiol,2001,87(5):643-645.

共引文献43252

同被引文献217

引证文献27

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部